Advice
Following an abbreviated submission
brinzolamide/timolol eye drops, suspension (Azarga) are accepted for use within NHS Scotland for the decrease of intraocular pressure (IOP) in adult patients with open-angle glaucoma or ocular hypertension for whom monotherapy provides insufficient IOP reduction.
The combination product allows patients to administer fewer drops at a modestly increased cost over separate administration of the constituents.
Download detailed advice57KB (PDF)
Medicine details
- Medicine name:
- brinzolomide/timolol eye drops (Azarga)
- SMC ID:
- 568/09
- Indication:
- Decrease of intraocular pressure (IOP) in adult patients with open-angle glaucoma or ocular hypertension for whom monotherapy provides insufficient IOP reduction
- Pharmaceutical company
- Alcon Laboratories UK Ltd
- BNF chapter
- Eye
- Submission type
- Abbreviated
- Status
- Accepted
- Date advice published
- 07 September 2009